101 related articles for article (PubMed ID: 310838)
1. Characterization of a xenoantiserum produced against three molar KCl-solubilized antigens obtained from a non-T, non-B (pre-B) acute lymphoblastic leukemia cell line.
LeBien TW; Hurwitz RL; Kersey JH
J Immunol; 1979 Jan; 122(1):82-8. PubMed ID: 310838
[No Abstract] [Full Text] [Related]
2. Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen.
Koshiba H; Minowada J; Pressman D
J Natl Cancer Inst; 1978 Oct; 61(4):987-91. PubMed ID: 81309
[TBL] [Abstract][Full Text] [Related]
3. Characterization of xenoantiserum produced against B cell acute lymphoblastic leukemia cell line.
Akagi T; Sonobe H; Miyoshi I; Yoshimoto S
Acta Med Okayama; 1982 Oct; 36(5):325-30. PubMed ID: 6184955
[TBL] [Abstract][Full Text] [Related]
4. [Human lymphocyte surface antigens. Part 1. Production and characterization of heteroantisera against cell lines derived from T-cell acute lymphoblastic leukemia and adult T-cell leukemia (author's transl)].
Yoshimoto S
Nihon Ketsueki Gakkai Zasshi; 1981 Nov; 44(6):1153-62. PubMed ID: 6977255
[No Abstract] [Full Text] [Related]
5. [Acute lymphoblastic leukemia in children. The use of antisera specific for lymphocyte populations in a classification trial].
Andary M; Clot J; Brochier J; Levallois C; Dossa D; Marguerite G; Jean R
Arch Fr Pediatr; 1979; 36(8):751-9. PubMed ID: 317241
[TBL] [Abstract][Full Text] [Related]
6. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
Negoro S; Seon BK
Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
[TBL] [Abstract][Full Text] [Related]
7. Markers of cellular differentiation in acute lymphoblastic leukemia.
Peiper SC; Stass SA
Arch Pathol Lab Med; 1982 Jan; 106(1):3-8. PubMed ID: 6976157
[TBL] [Abstract][Full Text] [Related]
8. Induction of several new antigens, including a T cell-associated antigen, following conversion of the EBV-negative B cell line RAMOS to EHRB-RAMOS by Epstein-Barr virus.
Rosenthal KS; Shuman H; Strominger JL
J Immunol; 1981 Aug; 127(2):746-54. PubMed ID: 6166685
[No Abstract] [Full Text] [Related]
9. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
Galli SJ; Adams RA
Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
[No Abstract] [Full Text] [Related]
10. [Lymphoblastic leukemia and immunological markers].
Ifrah N; Perrot JY; Marie JP; Boasson M; Zittoun R
Ann Med Interne (Paris); 1987; 138(7):527-32. PubMed ID: 3326452
[TBL] [Abstract][Full Text] [Related]
11. Detection and partial characterization of human T and B lymphocyte membrane antigens with antisera to HSB and SB cell lines.
Anderson JK; Metzgar RS
J Immunol; 1978 Jan; 120(1):262-71. PubMed ID: 304868
[No Abstract] [Full Text] [Related]
12. The use of column-bound B lymphocytes for absorption of antisera to T lymphocyte antigens.
Hudson L; Phillips B
J Immunol; 1973 Jun; 110(6):1663-6. PubMed ID: 4123285
[No Abstract] [Full Text] [Related]
13. Identification, enumeration, and isolation of B and T lymphocytes from human peripheral blood. Report of a WHO-IARC-sponsored workshop on human B and T cells, London, 15-17 July 1974.
Scand J Immunol; 1974; 3(5):521-32. PubMed ID: 4138857
[No Abstract] [Full Text] [Related]
14. Human T cell leukemia antigens on the cell membranes: purification molecular characterization, and preparation of specific antisera.
Seon BK; Negoro S; Minowada J; Yoshizaki K
J Immunol; 1981 Dec; 127(6):2580-8. PubMed ID: 6975329
[No Abstract] [Full Text] [Related]
15. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.
Gougos A; Letarte M
J Immunol; 1988 Sep; 141(6):1925-33. PubMed ID: 3262644
[TBL] [Abstract][Full Text] [Related]
16. Immunity in leukemia.
Gatti RA
Boll Ist Sieroter Milan; 1974; 53(1):suppl:275-81. PubMed ID: 4277522
[No Abstract] [Full Text] [Related]
17. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
18. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a subpopulation of human T lymphocytes reactive with an heteroantiserum to human brain.
Brouet J; Toben H
J Immunol; 1976 Apr; 116(4):1041-4. PubMed ID: 1082900
[TBL] [Abstract][Full Text] [Related]
20. Human leukemia antigen. I. Production and characterization of antisera.
Billing R; Terasaki PI
J Natl Cancer Inst; 1974 Dec; 53(6):1635-8. PubMed ID: 4612163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
